JINYU(SH:600201)2020-04-14 16:00Financial Performance - Net profit attributable to shareholders decreased by 5.13% to CNY 150,513,913.05 year-on-year[11] - Operating revenue rose by 9.62% to CNY 366,175,089.52 compared to the same period last year[11] - Basic and diluted earnings per share decreased by 7.14% to CNY 0.13[11] - The company anticipates significant changes in net profit compared to the same period last year, but no specific guidance was provided in the report[20] - The total profit for the first quarter of 2020 was 5,849,332.10, a decrease from 11,282,540.80 in the first quarter of 2019, representing a decline of approximately 48.1%[47] - Net profit for the first quarter of 2020 was 5,849,332.10, compared to 11,282,540.80 in the same period last year, indicating a decrease of about 48.1%[47] - Operating income for the first quarter of 2020 was 3,322,257.15, down from 4,513,635.73 in the first quarter of 2019, reflecting a decline of approximately 26.4%[47] - The company's net profit attributable to shareholders was 150,513,913.05 for the latest reporting period, down from 158,648,281.45, a decrease of approximately 5.7%[43] Cash Flow - Net cash flow from operating activities improved significantly to CNY 49,859,316.61, a turnaround from a negative cash flow of CNY -71,251,366.82 in the previous year[11] - Cash inflow from operating activities in the first quarter of 2020 was 262,252,461.54, compared to 295,773,643.57 in the first quarter of 2019, indicating a decrease of about 11.3%[50] - The net cash flow from investment activities was 237,196,156.69 RMB, a turnaround from -91,666,782.24 RMB in the previous year[52] - The net increase in cash and cash equivalents was 286,677,795.14 RMB, contrasting with a decrease of -213,063,490.34 RMB in the same period last year[54] - Cash outflow from financing activities totaled 449,919.99 RMB, compared to 50,031,489.73 RMB in the previous year, reflecting a decrease of 99.1%[56] Assets and Liabilities - Total assets increased by 4.89% to CNY 5,858,779,483.67 compared to the end of the previous year[11] - Total assets amounted to approximately $5.59 billion, with current assets at about $2.69 billion and non-current assets at approximately $2.89 billion[58] - Total liabilities reached approximately $716.78 million, with current liabilities totaling about $548.00 million and non-current liabilities at approximately $168.78 million[62] - Total liabilities were reported at $196.67 million, with current liabilities comprising $196.67 million[67] - The company has a total of approximately $1.20 billion in fixed assets and $454.44 million in construction in progress[58] Shareholder Information - The total number of shareholders at the end of the reporting period was 31,515[16] - The largest shareholder, Hong Kong Central Clearing Limited, holds 15.23% of the shares[16] - Shareholders' equity totaled approximately $4.87 billion, with total equity attributable to the parent company at about $4.65 billion[62] Operating Activities - Cash received from other operating activities increased by CNY 22.41 million, an increase of 109.29%, mainly due to government subsidies related to assets received by the biopharmaceutical industry[19] - Cash paid for purchasing goods and receiving services decreased by CNY 71.19 million, a decrease of 47.80%, mainly due to reduced material payments in the biopharmaceutical sector[19] - Cash paid for various taxes decreased by CNY 49.26 million, a decrease of 76.91%, primarily due to reduced corporate income tax and value-added tax payments during the reporting period[19] Research and Development - The company reported a research and development expense of $22,536,657.41 for Q1 2020, compared to $19,387,298.96 in Q1 2019, indicating a 11.1% increase[40] Other Financial Metrics - The company received government subsidies amounting to CNY 1,366,915.93 during the reporting period[11] - The company reported a non-operating loss of CNY -46,402.26, primarily due to other non-recurring losses[14] - The company reported a goodwill value of approximately $130.83 million[58] - The company has recognized deferred tax assets amounting to approximately $91.18 million[58] - The company has a total of $158.74 million in other payables, which includes $1.20 million in dividends payable[67]